This information was published on 2026-05-14T02:17:15 for IP Right Filed Published.
| Field | Value |
| (210) | 2653029 (IR 1917124) |
| (220) |
10 Apr 2026
|
| (300) |
KR, 13 Jan 2026, 4020260007539
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of inflammatory diseases. |
| (540) | Ocemma |
| (550) | Word |
| (730) |
CELLTRION, INC.
|
Find out more about publications on the About page.